Nuvectis Pharma Inc.
NVCT | NASDAQ
$22.19
+$0.21 (+0.96%)
Sep 22, 2026, 9:50 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 22.16M | 25.13M | 31.63M | 35.44M | 26.79M | 29.86M | 18.53M | 17.17M | 18.12M | 19.46M | 19.13M | 22.06M | 24.6M | 15.47M | 19.99M | 23.64M | 13.57M | 16.69M | 5.74M | 6.81M | 7.21M | n/a |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 824K | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 216K | 268K | 75K | 145K | 214K | 284K | 74K | 138K | 182K | 250K | 59K | 203K | 341K | 740K | 412K | 1.23M | 666K | 925K | 91K | n/a | n/a | n/a |
Total Current Assets | 22.38M | 25.4M | 31.71M | 35.59M | 27.01M | 30.15M | 18.61M | 17.31M | 18.3M | 19.71M | 19.19M | 22.26M | 24.94M | 16.21M | 20.41M | 24.87M | 14.24M | 17.62M | 5.83M | 6.81M | 7.21M | n/a |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 824K | n/a | n/a | n/a |
Total Assets | 22.38M | 25.4M | 31.71M | 35.59M | 27.01M | 30.15M | 18.61M | 17.31M | 18.3M | 19.71M | 19.19M | 22.26M | 24.94M | 16.21M | 20.41M | 24.87M | 14.24M | 17.62M | 6.66M | 6.81M | 7.21M | n/a |
Account Payables | 5.18M | 4.7M | 6.27M | 6.44M | 4.98M | 2.99M | 2.5M | 2.26M | 1.85M | 1.76M | 2.77M | 3.49M | 1.8M | 2.1M | 2.91M | 2.25M | 1.43M | 1.35M | 1.06M | 495K | 389K | 33K |
Deferred Revenue | 1.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 92K | 6.48M | 6.91M | 140K | 77K | 5.04M | 5.56M | 3.77M | 3.61M | 3.45M | 3.8M | 1.93M | 1.84M | 1.68M | 2.38M | 640K | 173K | 92K | 142K | n/a | n/a | 33K |
Total Current Liabilities | 13.29M | 11.18M | 13.3M | 11.58M | 10.14M | 9.19M | 8.89M | 6.32M | 5.77M | 5.69M | 6.98M | 5.58M | 4.61M | 3.93M | 6.19M | 4.49M | 2.74M | 3.06M | 2.42M | 495K | 389K | 33K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15.25M | 15.25M | 11.23M | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15.25M | 15.25M | 11.23M | n/a |
Total Liabilities | 13.29M | 11.18M | 13.3M | 11.58M | 10.14M | 9.19M | 8.89M | 6.32M | 5.77M | 5.69M | 6.98M | 5.58M | 4.61M | 3.93M | 6.19M | 4.49M | 2.74M | 3.06M | 17.67M | 15.74M | 11.61M | 33K |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Book Value | 9.08M | 14.22M | 18.41M | 24.01M | 16.87M | 20.95M | 9.71M | 10.99M | 12.53M | 14.02M | 12.2M | 16.69M | 20.33M | 12.27M | 14.22M | 20.37M | 11.5M | 14.56M | -11.01M | -8.93M | -4.4M | -33K |
Book Value Per Share | 0.39 | 0.61 | 0.84 | 1.06 | 0.79 | 1.05 | 0.50 | 0.64 | 0.74 | 0.85 | 0.70 | 1.04 | 1.34 | 0.83 | 0.97 | 1.45 | 0.90 | 1.14 | -0.87 | -0.70 | -0.35 | 0 |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -112.76M | -105.74M | -99.69M | -92.37M | -84.91M | -78.58M | -73.25M | -67M | -62.84M | -58.42M | -54.25M | -47.62M | -41.74M | -36.03M | -31.99M | -25.29M | -19.41M | -15.84M | -12.9M | -10.64M | -5.97M | -33K |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 9.08M | 14.22M | 18.41M | 24.01M | 16.87M | 20.95M | 9.71M | 10.99M | 12.53M | 14.02M | 12.2M | 16.69M | 20.33M | 12.27M | 14.22M | 20.37M | 11.5M | 14.56M | -11.01M | -8.93M | -4.4M | -33K |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NVCT